SCHEMBL7989799

SCHEMBL7989799

CCCCC(O)(CO)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SLC6A2 P23975 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
FDPS P14324 1/20 0.38
CSNK1E P49674 1/20 0.37
MMP1 P03956 1/20 0.37
MMP9 P14780 1/20 0.37
MMP13 P45452 1/20 0.37
LMNA P02545 1/20 0.36
CYP2D6 P10635 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TRPA1 O75762 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
TNNC1 P63316 5/20 0.36
SGPL1 O95470 1/20 0.36
S1PR4 O95977 1/20 0.36
S1PR1 P21453 1/20 0.36
GPR183 P32249 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989802 1.00 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19SLC6A2TAAR1
SCHEMBL14779954 0.85 GAA (0.44) CYP1A2CYP2C9CYP2C19SLC6A2TAAR1
SCHEMBL11106957 0.84 TAAR1 (0.41) CYP1A2CYP2C9CYP2C19SLC6A2TAAR1
SCHEMBL3273807 0.80 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19SLC6A2TAAR1
SCHEMBL27671625 0.79 CYP2C19 (0.48) CYP1A2CYP2C9CYP2C19SLC6A2TAAR1
SCHEMBL9545396 0.79 CYP2C19 (0.48) CYP1A2CYP2C9CYP2C19SLC6A2TAAR1
SCHEMBL7783601 0.78 TNNC1 (0.54) SLC6A2LMNATNNC1SGPL1S1PR4
SCHEMBL31427515 0.78 SLC6A2 (0.45) CYP1A2CYP2C9CYP2C19SLC6A2TAAR1
SCHEMBL2212796 0.77 TNNC1 (0.49) SLC6A2TAAR1CSNK1ESMN1; SMN2TNNC1
SCHEMBL10883736 0.77 CSNK1E (0.40) CYP1A2CYP2C9CYP2C19SLC6A2TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277871-B1 ANTICANCER AGENTS ABBOTT LABORATORIES 2001-08-21 US disclosed